The question is related to India business. So, what is the share of in-licensing portfolio in India Rx business and how that has grown?
Thank you. That is all from my side.
Questions across 2 calls
Vivek Agarwal
Citi
Cipla Limited
Sai Life Sciences Limited
Hi, thanks for the question, sir. Congrats on the exceptional quarter. If you look at your earlier commentary, you indicated that a couple of products have moved into the commercial stage, right? So, is it the growth in this quarter has been driven by some impact of the products moving into the commercial stage, or is it that existing molecules that have helped in the growth in this quarter? Thanks.
Okay. Sir, is it possible for you to quantify, for example, how much the growth that is coming from the new products?